Authors
Latest:
A Brave New World: Optimizing Access in Wake of COVIDThe top changes necessary in planning and designing pharma market access plans, including a revamp of the payer-value equation at pivotal points in the product life cycle.
Latest:
The Future of Medicine is SmartThis white paper describes how digitizing medicines can drive patient engagement, reduce non-adherence, and enhance supply chain visibility.
Latest:
In DOJ Crosshairs: Rethinking Commission-Based Deals With Independent ContractorsPharma companies should review their commission-based compensation arrangements with independent contractors to address enforcement risk under the Anti-Kickback Statute, in light of recent Department of Justice enforcement.
Latest:
The Value Cornerstone: Bridging the Pharma Marketing GapBrand positioning that targets HCPs is often irrelevant to the payer mindset. Fortunately, market access teams have an option, writes Ed Shankman.
Latest:
Foundational Questions in Data Reporting, Analytics to Meet Reimbursement-Directed Marketing GoalsMeasuring the relationship between a product’s reimbursement position and performance begins with gathering key data points for as many products as possible.
Latest:
Staying the Course: Double Down on Launch AgilityIn today’s fragmented commercial environment, navigating a more complex set of challenges while adapting new approaches to product launch is critical for biopharma brand teams.
Latest:
Health Equity Barriers in Oncology TrialsOvercoming persistent barriers to health equity in oncology trials will require innovation and cooperation.
Latest:
Leveraging Technology for Pharmaceutical CommercializationWith AI/ML and cognitive technologies set to become a key enabler of the pharma commercialization process, Srini Rajamani outlines how pharma companies can leverage tech effectively.
Latest:
How to Conduct More Impactful Patient and Caregiver Advisory BoardsLooking to hold an advisory board? Here are a few suggestions.
Latest:
Three Ways to Close the Urgent Talent GapThe industry has struggled to recruit talent for years, and the challenge is only getting more difficult. Pharma companies need to recruit differently.
Latest:
Patient Experience Breakthroughs: Leveraging the Latest Digital Tools and Techniques to Optimize your Patient Experience GoalsLearn how breakthrough patient experience strategies can help achieve your study goals in this upcoming webcast. Lead by renowned neuroscientist and behavioral economist Dr. Paul Glimcher, it’s the one webcast this year your team can’t afford to miss. Live: Tuesday, May 19, 2020 at 1pm EDT | 12pm CDT | 10am PDT On demand available after airing until May 19, 2021.
Latest:
Recruiting and Retaining Talent Is the Biggest Challenge Facing the Pharmaceutical IndustryRecent increases in employee burnout and turnover must be addressed.
Latest:
Flip the ScriptLife sciences transformations rarely fail because of what was in the plan. They fail because of what was not. Explore five trends that will determine their success in coming years.
Latest:
The Challenges of Worker Qualification Management in PharmaLife sciences companies uniquely tasked with meeting continuous and complex compliance-reporting requirements.
Latest:
A Generational Opportunity for Talent Pipeline DevelopmentCOVID-19 creates a unique chance to refocus STEM strategies.
Latest:
How to Connect with HCPs More EffectivelyRegardless of engagement mode pursued, personalization is the key.
Latest:
Recruitment Lessons from the COVID-19 PandemicFiona Huzarski outlines four key recruitment lessons that pharma can take from the coronavirus crisis and use to move forward and thrive.
Latest:
Crisis Communication Plans in PharmaThe pharmaceutical industry must have crisis communications prepared now to anticipate unforeseen events—especially those that impact public trust.
Latest:
Clues on Equity Engagement LevelsA survey of 18 biopharmas, measuring their scope and implementation across key health equity dimensions and activities, uncovers useful context as companies seek better alignment of these goals with overall strategy.
Latest:
Restoring Hope in Mental Illness Is a Collective MissionThe importance of equitable approaches to diagnosis and treatment.
Latest:
The Promise and Peril of AI in the Physical WorldThe use of artificial intelligence (AI) in drug development has been hampered by issues that have caused a gap between AI’s potential and its full utilization in this space.
Latest:
Action Through Engagement: Alleviating COVID Concerns in Patients with Underlying ConditionsIt’s important that care for people with pre-existing conditions or at risk from serious diseases does not fall by the wayside.
Latest:
Better Supply Chains Can Better Tackle Threats to Public HealthTo effectively combat the looming threat of antimicrobial resistance, we must prioritize working together to strengthen and more responsibly manage global supply chains.
